Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Fortress Biotech (FBIO) over the last 13 years, with Q3 2025 value amounting to -$1.7 million.

  • Fortress Biotech's Other Working Capital Changes rose 1558.57% to -$1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.2 million, marking a year-over-year decrease of 81851.85%. This contributed to the annual value of -$968000.0 for FY2024, which is 407813.67% down from last year.
  • Fortress Biotech's Other Working Capital Changes amounted to -$1.7 million in Q3 2025, which was up 1558.57% from $21000.0 recorded in Q2 2025.
  • Fortress Biotech's Other Working Capital Changes' 5-year high stood at $7.2 million during Q1 2021, with a 5-year trough of -$3.4 million in Q2 2024.
  • Its 5-year average for Other Working Capital Changes is $301280.7, with a median of $21000.0 in 2025.
  • As far as peak fluctuations go, Fortress Biotech's Other Working Capital Changes soared by 173206.11% in 2021, and later tumbled by 1274923.77% in 2024.
  • Over the past 5 years, Fortress Biotech's Other Working Capital Changes (Quarter) stood at -$743000.0 in 2021, then skyrocketed by 653.57% to $4.1 million in 2022, then fell by 1.17% to $4.1 million in 2023, then dropped by 27.8% to $2.9 million in 2024, then plummeted by 159.42% to -$1.7 million in 2025.
  • Its last three reported values are -$1.7 million in Q3 2025, $21000.0 for Q2 2025, and -$2.4 million during Q1 2025.